Amylyx Pharmaceuticals Inc

NASDAQ:AMLX

2.62

+0.13 (+5.22%)

7:18:00 PM EDT: $2.60 -0.02 (-0.76%)

Amylyx Pharmaceuticals Inc Stock, NASDAQ:AMLX

43 Thorndike Street, Cambridge, Massachusetts 02141

United States of America

Phone: +1.617.682.0917

Number of Employees: 384

http://www.amylyx.com

Description

Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.